Search peptide profiles, FDA-approved drugs, research-stage compounds, clinical updates, safety notes, and citation-backed deep dives.
Browse the A–Z index or ask the AI assistant a question.
Laboratory testing · Coming soon
One coded sample. Three facilities testing independently. All three reports returned to the client.
PeptideSciences101 is preparing a coded-sample laboratory testing program using three independent facilities. Each facility will test independently without receiving the client's or source's identity.
When reports differ, those differences will remain visible. No report will be replaced by a selected, blended, or averaged result.
Analytical testing does not establish clinical safety, effectiveness, or suitability for treatment.
Live reference activity
FDA labels, DailyMed, ClinicalTrials.gov, and PubMed-indexed studies.
Clinical trials are separated from animal, in-vitro, and mechanistic evidence.
Approved drugs are clearly separated from research-stage peptides.
Unapproved compounds are not presented as treatments.
Each profile shows its evidence grade, or says plainly that editorial review is still pending.
Profiles are grouped by what the evidence actually shows — from FDA-approved drugs to compounds with only preclinical data. The two evidence buckets count only profiles whose grade has completed editorial review; the two regulatory buckets cover the whole catalog.
100 profiles are awaiting editorial review and carry no evidence grade yet, so they are not counted in the Human evidence or Preclinical buckets. How we grade evidence
Body Protection Compound-157 is a synthetic peptide derived from a protective protein sequence found in gastric juice. It is commonly discussed for tissue repair, but human clinical evidence remains limited.
A field guide connecting inherited DNA to the peptides cells make — and how that differs from making one in a lab. Nine chapters plus a reference atlas. No cost — sign in to read.
Read the guide →